DOCK4 and neoplasm: Mutations or reduced expression of DOCK4 is related to malignancies in breast (Kobayashi et al., 2014), lung (Yu et al., 2015), brain (Debruyne et al., 2018) and blood tissues (Sundaravel et al., 2019) as well as tumor metastasis (Hiramoto et al., 2006).